CTRI/2025/02/081243RecruitingPhase 2/3
A Randomized Clinical Trial To Evaluate The Efficacy Of Go-Ghrita Aschyotana With And Without Shadanga Guggulu Orally In The Management Of Shushkakshipaka W.S.R. To Computer Vision Syndrome(CVS)
Madan Mohan Malviya Government Ayurved College Udaipur Rajasthan1 site in 1 country60 target enrollmentStarted: April 1, 2025Last updated:
Trial Snapshot
- Phase
- Phase 2/3
- Status
- Recruiting
- Sponsor
- Enrollment
- 60
- Locations
- 1
- Primary Endpoint
- Improvement in signs and symptoms of Shushkakshipaka w.s.r. to Computer Vision Syndrome(CVS) after treatment.
Study Overview
Brief Summary
This is a clinical trial to compare efficacy of Go- Ghrita Aschyotana and Shadanga Guggulu on Shushkakshipaka with special reference to Computer Vision Syndrome. In this trial 2 groups each of 30 patients will be selected. Group A will be administered with Go-Ghrita Ashchyotana and oral administration of Shadanga Guggulu Vati 2 BD with lukewarm water along with counseling for changing the working style and standard. Group B will be administered with Go-Ghrita Ashchyotana only.
Study Design
- Study Type
- Interventional
- Allocation
- Coin toss, Lottery, toss of dice, shuffling cards etc
- Masking
- None
Eligibility Criteria
- Ages
- 18.00 Year(s) to 60.00 Year(s) (—)
- Sex
- All
Inclusion Criteria
- •Patients using computer or any visual display terminal at least 3 hours per day presenting with clinical features of 1.Netrayasa (Eye strain) 2.Avila Darshana (Blurred vision) 3.Shiro abhitapa (Headache) 4.Netra raga (conjunctival congestion) 5.Netra Daha (Burning sensation) 6.Vishushkatva (Dryness) 7.Slow refocusing 8.Excessive fatigue (Neck/Shoulder/Back pain).
Exclusion Criteria
- •1.Patients suffering from symptoms of dry eye due to causes other than excess exposure to visual display terminals.
- •2.Patients suffering from systemic illness or taking medications which are known to affect tear quantity and quality.
- •3.Complicated case with acute/chronic infective infections of lid, conjunctiva, cornea and sclera.
Outcomes
Primary Outcomes
Improvement in signs and symptoms of Shushkakshipaka w.s.r. to Computer Vision Syndrome(CVS) after treatment.
Time Frame: 30 days.
Secondary Outcomes
- Improvement in other associated symptoms.(15th day, 30th day)
Investigators
Dr Rishabh Sikarwal
Madan Mohan Malviya Government Ayurved College, Udaipur(313001), Rajasthan, India
Study Sites (1)
Loading locations...
Similar Trials
Not yet recruiting
Phase 2/3
A Clinical study to evaluate the efficacy of Vishwadi Guggulu and Rasna Guggulu with Sahacharadi Taila Matra Basti in treating Sciatica.CTRI/2025/02/081151Dr Joylin Joshina Jathanna60
Not yet recruiting
Phase 2
Effect of Guduchi Sheetkashay and Dhanyak Sheetkashay in the management of Garbhini ChardiCTRI/2025/10/096290Dr Neha Subhash Rathod60
Not yet recruiting
Phase 2
EFFECT OF SHUNTHYADI CHURNA AND SHATAVARI TAILA MATRA BASTI ON HEAVY MENSUSCTRI/2024/11/076564Madan Mohan Malviya Govt. Ayurved College Udaipur30
Not yet recruiting
Phase 2/3
A Study of Triphala, Shunthi, Nimba, Lodhra and Atarushaka Kwatha Aashchyotan 2drops four times a day In Kaphabhishyanda with special reference To Simple Allergic conjunctivitis.CTRI/2025/09/094885vdswapnali ramesh patekar33
Not yet recruiting
Phase 2/3
Efficacy of Panchatikta Ghrita Guggulu over Lakshadi Guggulu after Panchaprasrta Basti in management of Asthishosha (Osteoporosis)CTRI/2025/10/096254All India Institute of Ayurveda,54